EXOME: Biotech • Healthcare • Life Sciences

Boston
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs

Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week

$96M

Monte Rosa Therapeutics

Ex-Radius Health Exec Carmona Joins Rubius as Chief Financial Officer

Freeline Therapeutics Promotes Corbau to Chief Scientific Officer

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders
Frank Vinluan | San Diego
Tau-Targeting Alzheimer’s Drug from AC Immune, Roche Fails in Phase 2
Frank Vinluan | Europe
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function”
Frank Vinluan | Seattle
Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations
Sue Sutter | National
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week
Editors | Boston
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal
Frank Vinluan | San Francisco
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
Frank Vinluan | National
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
Frank Vinluan | Boston
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
Dan Stanton | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!